Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Biotech SPDR (NY: XBI )

94.20 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EST, Dec 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 127
Open 94.20
Bid (Size) 94.44 (20)
Ask (Size) 95.00 (20)
Prev. Close 94.20
Today's Range 94.20 - 94.20
52wk Range 79.98 - 105.47
Shares Outstanding 689,000
Dividend Yield 0.03%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
It’s Been A Tough Month For Healthcare Stocks
It’s been a very difficult month for the healthcare sector not only because of disappointing company news but also disruption caused by the election and future policy issues. 
Via Talk Markets
Topics ETFs Stocks / Equities
As The Market Churns
Stocks managed to grind their way higher on the day, while rates and the dollar rebounded from yesterday’s declines. 
Via Talk Markets
Topics ETFs Stocks / Equities

Performance

YTD
+4.40%
+4.40%
1 Month
-6.28%
-6.28%
3 Month
-4.91%
-4.91%
6 Month
+0.41%
+0.41%
1 Year
+12.21%
+12.21%

More News

Read More
Momentum Model For Trading SMID Biotech Stocks: Broad Rally Underway
Via Talk Markets
Topics ETFs Stocks / Equities
Is Biotech’s Bull Run Over? Examining Election Impacts
Via MarketBeat
Topics ETFs Government
Exposures Political
What To Do After The Worst Week For Healthcare Stocks Since March 2020?
Via Talk Markets
A Must See Chart For Prudent Investors, Trump To Help Tesla Dominate, Nvidia Heat Problem
Via Benzinga
Topics Government
Exposures Political
Post-Election Euphoria Turns Into Hangover; One New Swing Position
Via Talk Markets
Biotech Stocks Are Rallying: What Is Your Playbook?
Via Talk Markets
Wednesday's Rally Followed By Friday's
Via Talk Markets
Topics ETFs
Smaller Cap Biotechs Are In Season: How Are We Doing?
Via Talk Markets
Biotech Stocks Edge Higher. Could Trump 2.0 Mean More Innovation, Dealmaking?
Via Investor's Business Daily
Topics Government
Exposures Political
Volatility Hits Large Cap Biopharma: Active Rebalancing May Be Required
Via Talk Markets
Biotech Momentum Trades For The Q4 Rally
Via Talk Markets
AskSlim Market Week - Friday, Oct. 25
Via Talk Markets
Healthcare Sector Update: Choppy Days Are Here Again As Yields Rise
Via Talk Markets
Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce
Via Talk Markets
Stocks Drop On October 7, And Are Poised To Move Lower
Via Talk Markets
Topics Stocks
Exposures US Equities
Biotech Stocks Poised For Another Big Move In Q4
Via Talk Markets
Biotech Stocks : Are You A Trader Or A Longer Term Investor?
Via Talk Markets
BCYC: A Promising Play In The Biotech Sector
Via Talk Markets
Topics ETFs
A Biotech Breakout Will Be Led By Small Caps
Via Talk Markets
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Via MarketBeat
Topics ETFs Economy
Exposures Economy Interest Rates
The Momentum Is Building, The Markets Are Strong - Just Don’t Chase After Extended Winners
Via Talk Markets
The Door Is Open, Time For The Fed To Act
Via Talk Markets
Topics Economy
Exposures Interest Rates
Stocks Hit Pause As Economic Uncertainty Tempers The Rally
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.